2024 Q2 Form 10-Q Financial Statement

#000162828024022266 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.951M $2.786M $2.537M
YoY Change 68.92% 13.99% 14.33%
% of Gross Profit
Research & Development $8.309M $6.040M $5.707M
YoY Change 66.98% 22.64% 21.76%
% of Gross Profit
Depreciation & Amortization $89.00K $81.00K $76.00K
YoY Change 89.36% 68.75% 130.3%
% of Gross Profit
Operating Expenses $12.26M $8.826M $8.300M
YoY Change 67.6% 19.77% 19.73%
Operating Profit -$12.26M -$8.826M
YoY Change 67.6% 19.77%
Interest Expense $1.225M $81.00K $239.0K
YoY Change 629.17% -56.22% 74.45%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$11.04M -$8.469M -$8.061M
YoY Change 57.37% 18.63% 18.63%
Income Tax $1.000K $0.00
% Of Pretax Income
Net Earnings -$11.04M -$8.469M -$8.061M
YoY Change 57.36% 18.63% 18.63%
Net Earnings / Revenue
Basic Earnings Per Share -$0.17 -$0.29
Diluted Earnings Per Share -$0.17 -$0.29 -$0.40
COMMON SHARES
Basic Shares Outstanding 65.47M shares 65.47M shares 20.22M shares
Diluted Shares Outstanding 64.47M shares 28.75M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $94.46M $97.55M $23.77M
YoY Change 153.5% 221.88% -39.31%
Cash & Equivalents $17.12M $29.59M $23.77M
Short-Term Investments $77.34M $67.97M $0.00
Other Short-Term Assets $2.633M $821.0K $4.412M
YoY Change 156.88% -30.31% -10.31%
Inventory
Prepaid Expenses $3.183M $3.010M $3.010M
Receivables
Other Receivables
Total Short-Term Assets $100.3M $101.4M $28.18M
YoY Change 142.58% 193.52% -36.07%
LONG-TERM ASSETS
Property, Plant & Equipment $1.083M $1.086M $1.061M
YoY Change 124.69% 120.28% 97.95%
Goodwill
YoY Change
Intangibles $27.00K $30.00K $33.00K
YoY Change -30.77% -48.28% -46.77%
Long-Term Investments $1.469M $10.17M
YoY Change
Other Assets $21.00K $74.00K $0.00
YoY Change
Total Long-Term Assets $3.781M $12.69M $2.571M
YoY Change 65.54% 417.37% -2.5%
TOTAL ASSETS
Total Short-Term Assets $100.3M $101.4M $28.18M
Total Long-Term Assets $3.781M $12.69M $2.571M
Total Assets $104.1M $114.1M $30.75M
YoY Change 138.55% 208.36% -34.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $601.0K $406.0K $204.0K
YoY Change 66.02% -30.12% 16.57%
Accrued Expenses $923.0K $604.0K $691.0K
YoY Change 48.15% -9.99% -28.1%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $540.0K $1.334M
YoY Change -100.0% -85.47% -70.43%
Total Short-Term Liabilities $5.263M $5.682M $8.508M
YoY Change -36.04% -35.59% -27.01%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $675.0K $868.0K $1.055M
YoY Change -52.5% -45.68%
Total Long-Term Liabilities $675.0K $868.0K $1.055M
YoY Change -52.5% -45.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.263M $5.682M $8.508M
Total Long-Term Liabilities $675.0K $868.0K $1.055M
Total Liabilities $5.938M $6.550M $9.563M
YoY Change -38.47% -37.14% -28.77%
SHAREHOLDERS EQUITY
Retained Earnings -$532.7M -$521.7M -$513.2M
YoY Change 7.12% 6.4% 6.22%
Common Stock $631.0M $629.3M $534.4M
YoY Change 18.76% 21.75% 3.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $98.18M $107.6M $21.19M
YoY Change
Total Liabilities & Shareholders Equity $104.1M $114.1M $30.75M
YoY Change 138.55% 208.36% -34.18%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$11.04M -$8.469M -$8.061M
YoY Change 57.36% 18.63% 18.63%
Depreciation, Depletion And Amortization $89.00K $81.00K $76.00K
YoY Change 89.36% 68.75% 130.3%
Cash From Operating Activities -$11.64M -$8.742M -$6.125M
YoY Change 86.13% 7.74% -2.05%
INVESTING ACTIVITIES
Capital Expenditures $83.00K $229.0K $71.00K
YoY Change 22800.0% 12.7%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$78.32M $5.003M
YoY Change -622.1% -52.49%
Cash From Investing Activities -$83.00K -$78.54M $4.932M
YoY Change -623.66% -52.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -744.0K $93.11M -873.0K
YoY Change -105.63% -11665.84%
NET CHANGE
Cash From Operating Activities -11.64M -$8.742M -6.125M
Cash From Investing Activities -83.00K -$78.54M 4.932M
Cash From Financing Activities -744.0K $93.11M -873.0K
Net Change In Cash -12.46M $5.819M -2.066M
YoY Change -279.21% -4.29% -149.03%
FREE CASH FLOW
Cash From Operating Activities -$11.64M -$8.742M -$6.125M
Capital Expenditures $83.00K $229.0K $71.00K
Free Cash Flow -$11.72M -$8.971M -$6.196M
YoY Change 87.46% 10.55% -1.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8469000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7139000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
33291000 usd
CY2022Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2022Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20222672 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20222672 shares
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2786000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2444000 usd
CY2024Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
438000 usd
CY2023Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
415000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
81000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
185000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-8469000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-7139000 usd
CY2024Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-45000 usd
CY2023Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
12000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8514000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7127000 usd
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28746802 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28746802 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16844243 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16844243 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
21187000 usd
CY2024Q1 rgls Stock Issued During Period Value Stock Issued From Private Placement Net Of Offering Costs
StockIssuedDuringPeriodValueStockIssuedFromPrivatePlacementNetOfOfferingCosts
93897000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 usd
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
31000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
985000 usd
CY2024Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentBeforeTaxPortionAttributableToParent
-45000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-8469000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
107588000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
21000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-8469000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-7139000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
81000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
985000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
410000 usd
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
130000 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-56000 usd
CY2024Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
32000 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
31000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
0 usd
CY2023Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
4000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-445000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-669000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
202000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
406000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
39000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-290000 usd
CY2024Q1 rgls Increase Decrease In Accrued Research And Development Expenses
IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses
-221000 usd
CY2023Q1 rgls Increase Decrease In Accrued Research And Development Expenses
IncreaseDecreaseInAccruedResearchAndDevelopmentExpenses
-714000 usd
CY2024Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1794000 usd
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1183000 usd
CY2024Q1 rgls Operating Lease Right Of Use And Lease Liabilities Net Gain Loss
OperatingLeaseRightOfUseAndLeaseLiabilitiesNetGainLoss
-23000 usd
CY2023Q1 rgls Operating Lease Right Of Use And Lease Liabilities Net Gain Loss
OperatingLeaseRightOfUseAndLeaseLiabilitiesNetGainLoss
-18000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-149000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-274000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8742000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8114000 usd
CY2024Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
78315000 usd
CY2023Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 usd
CY2024Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0 usd
CY2023Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
15000000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
229000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-78544000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
14999000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
93897000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
32000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
21000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2024Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
826000 usd
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
826000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
93105000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-805000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5819000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6080000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23829000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24290000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29648000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30370000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29586000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29586000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30308000 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
62000 usd
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
62000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
62000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29648000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30370000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
45000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
148000 usd
CY2024Q1 rgls Financingfrom Sale Proceeds Debt Agreement Revenues
FinancingfromSaleProceedsDebtAgreementRevenues
651700000 usd
CY2024Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
107700000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Use of Estimates</span></div>Our condensed financial statements are prepared in accordance with GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in our financial statements and accompanying notes. An estimated loss contingency is accrued in our financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Although these estimates are based on our knowledge of current events and actions we may undertake in the future, actual results may ultimately differ from these estimates and assumptions.
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29509969 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14020658 shares
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
78184000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
45000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
78139000 usd
CY2023 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
0 usd
CY2024Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
105681000 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
23084000 usd
rgls Number Of Amendments
NumberOfAmendments
10 amendment
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65465251 shares
CY2024Q1 rgls Common Stock Voting Rights Votes
CommonStockVotingRightsVotes
1 vote
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7175000 shares
CY2024Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
52969000 shares
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
985000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
410000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
604000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
824000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
277000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1705000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
107000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1598000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
730000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
868000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001628280-24-022266-index-headers.html Edgar Link pending
0001628280-24-022266-index.html Edgar Link pending
0001628280-24-022266.txt Edgar Link pending
0001628280-24-022266-xbrl.zip Edgar Link pending
ex-311x20240331.htm Edgar Link pending
ex-312x20240331.htm Edgar Link pending
ex-321x20240331.htm Edgar Link pending
ex-51x20240331opinionofcoo.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rgls-20240331.htm Edgar Link pending
rgls-20240331.xsd Edgar Link pending
Show.js Edgar Link pending
rgls-20240331_def.xml Edgar Link unprocessable
rgls-20240331_cal.xml Edgar Link unprocessable
rgls-20240331_lab.xml Edgar Link unprocessable
rgls-20240331_pre.xml Edgar Link unprocessable
rgls-20240331_htm.xml Edgar Link completed